COMPETITIVE RESEARCH GRANT 2

BRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATION (BMSIC)

Object

Topic: Immunology.

Destination: Projects in the field of immunology related to Ozanimod (Zeposia UC) belonging to a class of drugs called sphingosine l-phosphate receptor modulators may participate in this call. Its action is to decrease the action of immune cells that can cause nerve damage.

Budget: Not indicated.

Duration: Not indicated

Are you interested in this call?

Are you interested?

Fill out the form below to receive more information: